Non-alcoholic fatty liver disease: a massive problem

od Day, Christopher P
Wydane w Clin Med (Lond) (2011)

Candidate gene case-control association studies: advantages and potential pitfalls

od Daly, Ann K, Day, Christopher P
Wydane 2001

Nonalcoholic fatty liver disease: new treatments

od Hardy, Timothy, Anstee, Quentin M., Day, Christopher P.
Wydane w Curr Opin Gastroenterol (2015)

Accuracy of hepatic adverse drug reaction reporting in one English health region

od Aithal, Guruprasad P, Rawlins, Michael D, Day, Christopher P
Wydane 1999

CYP2C9 polymorphism and warfarin dose requirements

od Daly, Ann K, Day, Christopher P, Aithal, Guruprasad P
Wydane 2002

Gut Microbiota and Lifestyle Interventions in NAFLD

od Houghton, David, Stewart, Christopher J., Day, Christopher P., Trenell, Michael
Wydane w Int J Mol Sci (2016)

Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes

od Houghton, David, Hardy, Timothy, Stewart, Christopher, Errington, Linda, Day, Christopher P., Trenell, Michael I., Avery, Leah
Wydane w Diabetologia (2018)

Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss

od Hallsworth, Kate, Fattakhova, Gulnar, Hollingsworth, Kieren G, Thoma, Christian, Moore, Sarah, Taylor, Roy, Day, Christopher P, Trenell, Michael I
Wydane 2011

Standardization of Nomenclature and Causality Assessment in Drug-Induced Liver Injury: Summary of a Clinical Research Workshop

od Fontana, Robert J., Seeff, Leonard B., Andrade, Raúl J., Björnsson, Einar, Day, Christopher P., Serrano, Jose, Hoofnagle, Jay H.
Wydane 2010

White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers

od Hardy, Timothy, Wells, Christopher, Kendrick, Stuart, Hudson, Mark, Day, Christopher P, Burt, Alastair D, Masson, Steven, Stewart, Stephen F
Wydane 2013

Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls

od Hallsworth, Kate, Thoma, Christian, Moore, Sarah, Ploetz, Thomas, Anstee, Quentin M, Taylor, Roy, Day, Christopher P, Trenell, Michael I
Wydane w Frontline Gastroenterol (2015)

Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

od ANGULO, PAUL, BUGIANESI, ELISABETTA, BJORNSSON, EINAR S., CHARATCHAROENWITTHAYA, PHUNCHAI, MILLS, PETER R., BARRERA, FRANCISCO, HAFLIDADOTTIR, SVANHILDUR, DAY, CHRISTOPHER P., GEORGE, JACOB
Wydane 2013

POLG determines the risk of sodium valproate induced liver toxicity

od Stewart, Joanna D., Horvath, Rita, Baruffini, Enrico, Ferrero, Iliana, Bulst, Stefanie, Watkins, Paul B., Fontana, Robert J., Day, Christopher P., Chinnery, Patrick F.
Wydane 2010

Serum Ferritin Levels Lack Diagnostic Accuracy for Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease

od Angulo, Paul, George, Jacob, Day, Christopher P., Vanni, Ester, Russell, Lee, Dela Cruz, Anna C., Liaquat, Hammad, Mezzabotta, Lavinia, Lee, Eun, Bugianesi, Elisabetta
Wydane 2013

Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease

od Aravinthan, Aloysious, Mells, George, Allison, Michael, Leathart, Julian, Kotronen, Anna, Yki-Jarvinen, Hannele, Daly, Ann K, Day, Christopher P, Anstee, Quentin M, Alexander, Graeme
Wydane 2014

Cardiac structure and function are altered in type 2 diabetes and Non-alcoholic fatty liver disease and associate with glycemic control

od Cassidy, Sophie, Hallsworth, Kate, Thoma, Christian, MacGowan, Guy A, Hollingsworth, Kieren G, Day, Christopher P, Taylor, Roy, Jakovljevic, Djordje G, Trenell, Michael I
Wydane w Cardiovasc Diabetol (2015)

A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease

od Stewart Stephen, King Barry P, Miele Luca, Patman Gillian L, Beale Gary S, Chattopadhyay Dipankar, Gray Joe, Hudson Mark, Day Christopher P, Manas Derek M, Reeves Helen L
Wydane 2009-08-01

A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease

od Gray, Joe, Chattopadhyay, Dipankar, Beale, Gary S, Patman, Gillian L, Miele, Luca, King, Barry P, Stewart, Stephen, Hudson, Mark, Day, Christopher P, Manas, Derek M, Reeves, Helen L
Wydane 2009

The Kruppel-Like Factor 6 Genotype Is Associated With Fibrosis in Nonalcoholic Fatty Liver Disease

od MIELE, LUCA, BEALE, GARY, PATMAN, GILLIAN, NOBILI, VALERIO, LEATHART, JULIAN, GRIECO, ANTONIO, ABATE, MARILENA, FRIEDMAN, SCOTT L., NARLA, GOUTHAM, BUGIANESI, ELISABETTA, DAY, CHRISTOPHER P., REEVES, HELEN L.
Wydane 2008

THE NATURAL HISTORY OF NONALCOHOLIC FATTY LIVER DISEASE WITH ADVANCED FIBROSIS OR CIRRHOSIS: AN INTERNATIONAL COLLABORATIVE STUDY

od Bhala, Neeraj, Angulo, Paul, van der Poorten, David, Lee, Eric, Hui, Jason M., Saracco, Giorgio, Adams, Leon A., Charatcharoenwitthaya, Punchai, Topping, Joanne H., Bugianesi, Elisabetta, Day, Christopher P., George, Jacob
Wydane 2011